This distributed ICTS is composed of the CIBER-BBN, CCMIJU and BIONAND. These three centres group together 27 complementary and coordinated units, located at different institutions, which in turn are distributed throughout seven Autonomous Communities: Andalusia, Aragon, Catalonia, Extremadura, Madrid, the Basque Country, and Valencia.
The research infrastructure is geared towards medical applications, offering a complete service that uses a single contact point model, involving the design and production of biomolecules, biomaterials, nanomaterials and their conjugates, as well as the characterization of these materials, tissues, medical devices, and systems from physicochemical, toxicological, and biological points of view, including in vivo preclinical validation.
These platforms belong to the area of Bioengineering, Biomaterials, and Nanomedicine (BBN), of the CIBER, a consortium that is part of the Institute of Health Carlos III (Ministry of Economy and Competitiveness). The CIBER-BBN has been carrying out its work since 2007, and is currently made up of 44 research groups, selected on the basis of their scientific excellence, working mainly within three scientific programs: Bioengineering and Medical Imaging, Biomaterials and Advanced Therapies, and Nanomedicine. The CIBER-BBN participates in NANBIOSIS with 20 Units, 9 of which are specialised in a la carte production of biomolecules (proteins, antibodies, and peptides), biomaterials and nanomateriales, conjugated or not, with different purposes and able to be categorised up to their pre-clinical validation by singular equipment available in other units such as the light-scattering “3D SLS & DLS,” >abbr title="nuclear magnetic resonance">NMR (10 equipments operating at magnetic fields between 5.8 and 14.1 Teslas) and fluorescence and bio-luminescence spectrophotometers, as well as micro CT, ToF-SIMS, and the Instron machines for mechanical characterisation, among others.